Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease

C O'Neill, AP Kiely, MF Coakley… - Biochemical Society …, 2012 - portlandpress.com
The quality control of protein homoeostasis deteriorates with aging, causing the
accumulation of misfolded proteins and neurodegeneration. Thus, in AD (Alzheimer's …

Potential roles of insulin and IGF-1 in Alzheimer's disease

L Gasparini, H Xu - Trends in neurosciences, 2003 - cell.com
Aging is characterized by a significant decline of metabolic and hormonal functions, which
often facilitates the onset of severe age-associated pathologies. One outstanding example of …

The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease

E Carro, I Torres-Aleman - European journal of pharmacology, 2004 - Elsevier
Cellular and molecular processes leading to abnormal accumulation of β amyloid in the
brain are slowly being uncovered. A potential involvement of insulin and insulin-like growth …

The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's Disease

GM Cole, SA Frautschy - Experimental gerontology, 2007 - Elsevier
Although increased lifespan is associated with reduced insulin signaling, insulin signaling is
essential for neuronal development and survival. Insulin resistance is central to Type II …

[HTML][HTML] Insulin and IGF1 signalling pathways in human astrocytes in vitro and in vivo; characterisation, subcellular localisation and modulation of the receptors

CJ Garwood, LE Ratcliffe, SV Morgan, JE Simpson… - Molecular brain, 2015 - Springer
Background The insulin/IGF1 signalling (IIS) pathways are involved in longevity regulation
and are dysregulated in neurons in Alzheimer's disease (AD). We previously showed …

PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease

C O'Neill - Experimental gerontology, 2013 - Elsevier
The normal on and off switching of the PI3-K (phosphoinositide 3-kinase)/Akt pathway,
particularly by its major activators insulin and IGF-1 (insulin-like growth factor-1), is a …

Targeting insulin-like growth factor-1 to treat Alzheimer's disease

I Torres-Aleman - Expert opinion on therapeutic targets, 2007 - Taylor & Francis
The 'amyloid cascade hypothesis' proposes that disturbances in amyloid metabolism cause
Alzheimer's disease (AD). However, a comprehensive explanation of the mechanisms …

Linking insulin with Alzheimer's disease: emergence as type III diabetes

S Ahmed, Z Mahmood, S Zahid - Neurological Sciences, 2015 - Springer
Alzheimer's disease (AD) has characteristic neuropathological abnormalities including
regionalized neurodegeneration, neurofibrillary tangles, amyloid beta (Aβ) deposition …

[HTML][HTML] Therapeutic targets of brain insulin resistance in sporadic Alzheimer's disease

SM de la Monte - Frontiers in bioscience (Elite edition), 2012 - ncbi.nlm.nih.gov
Growing evidence supports roles for brain insulin and insulin-like growth factor (IGF)
resistance and metabolic dysfunction in the pathogenesis of Alzheimer's disease (AD) …

Beta-amyloid monomer and insulin/IGF-1 signaling in Alzheimer's disease

ML Giuffrida, F Tomasello, F Caraci, S Chiechio… - Molecular …, 2012 - Springer
Alzheimer's disease is the most common form of dementia among older people and is still
untreatable. While β-amyloid protein is recognized as the disease determinant with a pivotal …